Report Categories
View AllRecent Articles
View All
Biogen Inc BIIB Secures Felzartamab Rights to Challenge Darzalex Dominance in Chinas Multiple Myeloma Market
Arbutus ABUS Stock Future Outlook Analysis Arbutus posts 44 EPS beat as narrower loss tops analyst estimates
AQNB Alg P and U 2079 reports Q4 2025 earnings per share 34 percent above consensus estimates shares remain unchanged
Simon Property Group SPG Poised for Q1 2026 Outperformance Following Peer Kimcos Strong Retail REIT Results
CNI CN Rail slides 593 after Q1 2026 EPS lands 18 below consensus analyst estimates
LECO Lincoln posts small Q4 2025 EPS beat shares edge down 12 on cautious investor sentiment
RMD ResMed delivers 166 percent Q1 2001 EPS beat shares tick slightly higher in daily trading